[email protected]

Category: Pharma Audits

Visual Inspection 4.0

Pharma Audits

Visual Inspection 4.0: Machines That Never Miss a Defect (And Regulators Love It)

April 16, 2026 No Comments

Annex 15 Revision

Pharma Audits

Annex 15 Revision: Key Impacts on Qualification and Validation for GDP Operators

March 31, 2026 No Comments

EU Pharma Package

Pharma Audits

EU Pharma Package 2026: What It Means for GMP/GDP Operators Now

March 19, 2026 No Comments

Pharma Audits

Pharma Audits

Third‑Party PV Subcontractors in the Crosshairs: How to Audit‑Proof Your Vendor Agreements

March 10, 2026 No Comments

FDA Warning Letter support

Pharma Audits

Why 87% of FDA Warning Letters Require External GMP Consultants

February 12, 2026 No Comments

Pharmacovigilance Practice

Pharma Audits

QPPV Services for MAHs: Defining Real Oversight in Outsourced PV Models

January 29, 2026 No Comments

Pharmacovigilance Audit

Pharma Audits

Do You Need a Pharmacovigilance Audit? Key Signs for UK Pharma Companies

January 27, 2026 No Comments

Internal vs External Audits

Pharma Audits

Internal vs External Audits in GMP and Pharmacovigilance: What UK Regulators Expect

January 22, 2026 No Comments

Pharmacovigilance Audit

Pharma Audits

Top GMP and Pharmacovigilance Audit Findings and How to Avoid Them

January 20, 2026 No Comments

MHRA Inspection Readiness

Pharma Audits

MHRA Inspection Readiness: A Detailed January Checklist for UK Pharma Companies

January 15, 2026 No Comments

Let’s build a GxP-compliant future together.

Have a project in mind?

Partner with us to elevate your quality systems, ensure compliance, and drive meaningful business transformation.

Built with passion and purpose. Helping you grow smarter, not harder.

QUICK LINKS

CONTACT US

[email protected]

Newsletter Signup

Subscribe to our newsletter for the latest insights

Copyright © 2026 Quality Vigilance Ltd | All Rights Reserved || Powered by Prabisha Consulting